These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31809611)

  • 1. Design and Optimization of PLGA Particles to Deliver Immunomodulatory Drugs for the Prevention of Skin Allograft Rejection.
    Shahzad KA; Naeem M; Zhang L; Wan X; Song S; Pei W; Zhao C; Jin X; Shen C
    Immunol Invest; 2020 Oct; 49(7):840-857. PubMed ID: 31809611
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants.
    Li Y; Frei AW; Labrada IM; Rong Y; Liang JP; Samojlik MM; Sun C; Barash S; Keselowsky BG; Bayer AL; Stabler CL
    Front Immunol; 2021; 12():653088. PubMed ID: 34122410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection.
    Keshavarz Shahbaz S; Foroughi F; Soltaninezhad E; Jamialahmadi T; Penson PE; Sahebkar A
    Expert Opin Drug Deliv; 2020 Jun; 17(6):767-780. PubMed ID: 32223341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific killer polylactic-co-glycolic acid (PLGA) microspheres can prolong alloskin graft survival in a murine model.
    Wang W; Fang K; Wang X; Li M; Wu Y; Chen F; Shahzad KA; Gu N; Shen C
    Immunol Invest; 2015; 44(4):385-99. PubMed ID: 25942349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro and nanoparticle drug delivery systems for preventing allotransplant rejection.
    Fisher JD; Acharya AP; Little SR
    Clin Immunol; 2015 Sep; 160(1):24-35. PubMed ID: 25937032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus-loaded methoxy poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats.
    Liu D; Wu Q; Chen W; Lin H; Liu Y; Liang H; Zhu F
    Eur J Pharm Sci; 2019 May; 133():104-114. PubMed ID: 30928512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.
    Ding D; Zhu Q
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1041-1060. PubMed ID: 30184728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats.
    Pan Q; Xu Q; Boylan NJ; Lamb NW; Emmert DG; Yang JC; Tang L; Heflin T; Alwadani S; Eberhart CG; Stark WJ; Hanes J
    J Control Release; 2015 Mar; 201():32-40. PubMed ID: 25576786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.
    Shahzad KA; Wan X; Zhang L; Pei W; Zhang A; Younis M; Wang W; Shen C
    Drug Deliv; 2018 Nov; 25(1):703-715. PubMed ID: 29508634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of genetically modified allograft to deliver local immunomodulatory molecule with minimal systemic toxicity in a rat model of allogeneic skin flap transplantation.
    Fu S; Yang Y; Xiao B; Li Y; Yi CG; Xia W; Guo SZ
    Transplant Proc; 2010 Nov; 42(9):3815-9. PubMed ID: 21094862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival.
    Shirali AC; Look M; Du W; Kassis E; Stout-Delgado HW; Fahmy TM; Goldstein DR
    Am J Transplant; 2011 Dec; 11(12):2582-92. PubMed ID: 21883921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of FK506-loaded PLGA nanoparticles prolongs cardiac allograft survival.
    Deng C; Chen Y; Zhang L; Wu Y; Li H; Wu Y; Wang B; Sun Z; Li Y; Lv Q; Yang Y; Wang J; Jin Q; Xie M
    Int J Pharm; 2020 Feb; 575():118951. PubMed ID: 31843550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New evidence for a role of allograft accommodation in long-term tolerance.
    Heslan JM; Renaudin K; Thebault P; Josien R; Cuturi MC; Chiffoleau E
    Transplantation; 2006 Nov; 82(9):1185-93. PubMed ID: 17102770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.
    Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B
    Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.